Jane Street’s Whitehawk Therapeutics WHWK Stock Holding History
Bought
Maintained
Sold
Other funds holding WHWK
YF
ACP
QF
SCM
O
ACA
SL
KCA
Jane Street's WHWK Position: Q2 2026 in Review
Jane Street sold out of Whitehawk Therapeutics (WHWK) in Q2 2026, closing a stake of 151,110 shares — an estimated $521K sold.
Jane Street first reported a position in WHWK in Q3 2018 and held it in 17 quarters. The position peaked at $683K in Q1 2022. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.
- Jane Street reported no remaining Whitehawk Therapeutics position as of Q2 2026 after selling out during the quarter.
- Jane Street sold 151,110 Whitehawk Therapeutics shares in Q2 2026, an estimated $521K.
- Jane Street first reported a position in Whitehawk Therapeutics in Q3 2018 and held it in 17 quarters.
- Jane Street's Whitehawk Therapeutics position peaked at $683K in Q1 2022.
- 77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.